ÖNGEN, H. 2012. Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial. LANCET , vol.379, no.9811 , 123-129.

ÖNGEN, H., (2012). Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial. LANCET , vol.379, no.9811, 123-129.

ÖNGEN, Hürremgül. "Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial," LANCET , vol.379, no.9811, 123-129, 2012

ÖNGEN, Hürremgül. "Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial." LANCET , vol.379, no.9811, pp.123-129, 2012

ÖNGEN, H. (2012) . "Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial." LANCET , vol.379, no.9811, pp.123-129.

@article{article, author={Hürremgül ÖNGEN}, title={Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial}, journal={LANCET}, year=2012, pages={123-129} }